Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antonio Quintero-Ramos has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perfil clínico de pacientes con inmunodeficiencia secundaria en terapia sustitutiva con inmunoglobulina

    by Alicia Méndez-Gómez, Noemí Gómez-Hernández, Margarita Ortega-Cisneros, Bricia Melissa Gutiérrez-Zepeda, Antonio de Jesús Quintero-Rodríguez, Luis Alberto Duran-Marín, Marya Lizzeth Rosaldo-Solís, Antonio Quintero-Ramos

    Resumen Introducción: la inmunodeficiencia secundaria (SID) es un trastorno en el que el sistema inmunológico se ve comprometido por factores externos o adquiridos, reduciendo la cantidad o la función de las inmunoglobulinas. Esta condición incrementa la necesidad de interconsulta, seguimiento y terapia sustitutiva, lo que a su vez eleva los costos en salud. A la fecha, existen pocos estudios que caractericen clínicamente a los pacientes con SID; por ello, conocer su perfil permitirá un mejor abordaje y tratamiento. Objetivo: describir el perfil clínico de pacientes con SID que reciben terapia sustitutiva con inmunoglobulina humana (IgG-RT). Material y métodos: se realizó un estudio observacional retrospectivo mediante la revisión de 40 expedientes clínicos de pacientes con SID en tratamiento con IgG-RT. Se analizaron factores de riesgo y los beneficios de la terapia sustitutiva. Resultados: la edad promedio fue de 48 años, con predominio de mujeres (62.5%). Las patologías más frecuentes fueron las reumatológicas (38%), seguidas de las hematológicas (31%) y las enfermedades perdedoras de proteínas (27%). Todos los pacientes habían recibido corticoesteroides en combinación con otro inmunosupresor, y el 77.5% también había sido tratado con rituximab. Se registraron infecciones en el 50% de los casos; sin embargo, solo el 35% recibió profilaxis. Se documentó recaída en el 22.5% de los pacientes y una mortalidad del 2.5%. Conclusiones: el uso de corticoesteroides e inmunosupresores, específicamente rituximab, constituyó la principal causa de SID, asociada predominantemente a enfermedades reumatológicas y hematológicas.

  • Open Access

    IL4 Gene Variants rs2243250 and rs2243248 and Their Association with Clinical Phenotypes of Severe Asthma in the Mexican Population: In Silico Functional Analysis and Regulatory Implications

    by Ingrid Berenice Montoya-Delgado, Itzel Vianey Ochoa-García, Zaira Lorena Escobedo-Salcedo, Margarita Ortega-Cisneros, Alicia Del Toro-Arreola, Adrián Daneri-Navarro, Yeminia Valle, María Enriqueta Nuñez-Nuñez, Beatriz Bayardo-Gutierrez, Antonio Quintero-Ramos

    Severe asthma (SA) is a chronic respiratory disease characterized by clinical heterogeneity and poor therapeutic response. Variants in the IL4 gene, including rs2243250 and rs2243248, have been associated with asthma susceptibility and severity in different populations; however, their role in the Mexican population remains unclear. This study evaluated the association of IL4 promoter variants rs2243250 and rs2243248 with SA and related clinical characteristics in a Mexican population using genetic and in silico approaches. In total, 106 patients with SA and 180 healthy individuals were included. Genotyping was performed using allelic discrimination assays with TaqMan® probes, and associations between genotypes and clinical variables were assessed. No significant differences in allele or genotype frequencies were observed between groups. However, the rs2243250 TT genotype was associated with nocturnal symptoms (OR = 3.03, 95% CI = 1.31–7.00, p = 0.009) and increased use of rescue medication (OR = 3.16, 95% CI = 1.41–7.07, p = 0.005). The rs2243248 TG/GG genotypes were associated with epithelial allergy (p < 0.05). In silico analysis suggested a regulatory role for both variants. These findings suggest that IL4 variants may not influence overall disease risk but could modulate clinical features of asthma severity.

  • Open Access

    IL4 Gene Variants rs2243250 and rs2243248 and Their Association with Clinical Phenotypes of Severe Asthma in the Mexican Population: In Silico Functional Analysis and Regulatory Implications

    by Ingrid Berenice Montoya-Delgado, Itzel Vianey Ochoa-García, Zaira Lorena Escobedo-Salcedo, Margarita Ortega-Cisneros, Alicia Del Toro-Arreola, Adrián Daneri-Navarro, Yeminia Valle, María Enriqueta Nuñez-Nuñez, Beatriz Bayardo-Gutierrez, Antonio Quintero-Ramos

    Severe asthma (SA) is a chronic respiratory disease characterized by clinical heterogeneity and poor therapeutic response. Variants in the IL4 gene, including rs2243250 and rs2243248, have been associated with asthma susceptibility and severity in different populations; however, their role in the Mexican population remains unclear. This study evaluated the association of IL4 promoter variants rs2243250 and rs2243248 with severe asthma and its clinical characteristics in a Mexican population using genetic and in silico approaches. A total of 106 patients with SA and 180 healthy individuals were included. Genotyping was performed using allelic discrimination assays with TaqMan® probes, and associations between genotypes and clinical variables were assessed. No significant differences in allele or genotype frequencies were observed between groups. However, the rs2243250 TT genotype was associated with nocturnal symptoms (OR = 3.03, 95% CI = 1.31–7.00, p = 0.009) and increased use of rescue medication (OR = 3.16, 95% CI = 1.41–7.07, p = 0.005). The rs2243248 TG/GG genotypes were associated with epithelial allergy (p < 0.05). In silico analysis suggested a regulatory role for both variants. These findings suggest that IL4 variants may not influence overall disease risk but could modulate clinical features of asthma severity.

  • Open Access

    Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer’s Disease in Carriers of the Mexican Founder Mutation PSEN1 A431E

    by Celeste Patricia Gazcón-Rivas, Iliannis Yisel Roa-Bruzón, Luis Félix Duany-Almira, Cesar Aly Valdéz-Gaxiola, Sofia Dumois-Petersen, Luis Eduardo Figuera-Villanueva, Antonio Quintero-Ramos, Carmen Magdalena Gurrola-Díaz, Daniel Ortuño-Sahagun, Yeminia Valle, et al.

    Background: Early-onset Alzheimer’s disease (EOAD) caused by autosomal dominant mutations provides a deterministic framework for investigating genetic modifiers of neurodegeneration. Telomere biology has emerged as a central regulator of genomic stability, cellular ageing, and stress response integration, yet its role in EOAD, particularly in under-represented populations, remains poorly defined. Methods: We conducted a cross-sectional case–control study to evaluate the genetic distribution, disease association, and predicted regulatory consequences of common variants in the telomere maintenance genes TERT and TERC in individuals from Western Mexico. The EOAD group comprised genetically confirmed carriers of the PSEN1 p.Ala431Glu (A431E) founder mutation with clinical EOAD (n = 69), and controls were unrelated individuals without dementia (n = 179). Five common variants were analyzed: rs2242652, rs2853677, rs2736100, and rs10069690 (TERT), and rs12696304 (TERC). Results: Genotype distributions in controls conformed to the Hardy–Weinberg equilibrium. Single-variant analyses showed no significant allele-level associations. Most TERT variants did not show significant allele-level associations with EOAD. However, a preliminary genotype-level enrichment for the GC allele at rs12696304 (TERC) was observed among EOAD cases compared with controls; allele-level associations were not significant. Linkage disequilibrium analysis revealed low r2 values (ACTRT3 in whole blood and pituitary, as well as for LRRC34 in the cerebellar hemisphere, suggesting a potential regulatory network within the TERC locus (3q26.2). Conclusions: Overall, common regulatory variants in TERT did not show strong independent effects on EOAD susceptibility in PSEN1 A431E carriers. However, the convergence of association patterns, functional annotation, and regulatory evidence provides hypothesis-generating support for the TERC locus (3q26.2), particularly rs12696304, as a candidate region for further investigation. Additional studies integrating telomere dynamics, functional validation, and multi-omics analyses are needed to clarify the role of telomere biology in the pathogenesis of autosomal dominant EOAD.


  • Open Access

    Expression Patterns of LALBA and Nucleolin and Their Clinical, Prognostic, and Immune Relevance in Breast Cancer Tissues of Mexican Patients

    by Mariana Navarro-Real, Juan Omar Zavala-López, Juliana Marisol Godínez-Rubí, Antonio Quintero-Ramos, Alicia Del Toro-Arreola, Ramon Franco-Topete, Ángel Quiroz Bolaños, Antonio Topete, Adrián Daneri-Navarro

    Breast cancer is the most common and deadliest cancer among women. While overexpression of specific markers guides disease stratification and has enabled the development of targeted therapies, identifying new therapeutic targets remains critical, particularly for aggressive subtypes lacking effective treatments. This study evaluated the expression of α-Lactalbumin (LALBA) and nucleolin (NCL) in breast cancer tissues from Mexican patients using gene expression analysis and immunohistochemistry. LALBA, a major milk protein normally expressed only during late pregnancy and lactation, was detected in nearly all tumor samples and showed higher levels in aggressive subtypes, with overexpression displaying a slight trend toward poorer overall survival. NCL, a multifunctional nucleolar protein, exhibited predominantly nuclear localization, with moderate expression associated with improved survival. Both proteins correlated with tumor immune features, including increased tumor-infiltrating lymphocytes (TILs) and PD-L1 expression for LALBA, and elevated CD8+ T cells, PD-L1, and TIM-3 expression for NCL. Overall, these findings suggest that LALBA and NCL are associated with tumor aggressiveness, immune context, and survival trends in breast cancer. Additional studies in larger cohorts are needed to define their clinical relevance.

  • Open Access

    TP53 IVS3 16 bp Variant and Breast Cancer Risk in Western Mexican Women: A Case–Control Study

    by Mariana Araiza-Guzmán, Bricia M. Gutiérrez-Zepeda, Ana M. Saldaña-Cruz, Ingrid B. Montoya-Delgado, Diana Rubio-Delgado, Pablo Benítez-Villa, Diana M. Hernández-Corona, Adrian Daneri-Navarro, Alicia del Toro-Arreola, Jazmin Márquez-Pedroza, et al.

    Background: Mutations in the TP53 gene can alter its tumor suppressor functions, thereby promoting oncogenic activity. The TP53 IVS3 16 bp genetic variant overlaps with nucleotide sequences that can alter regulatory structures, potentially affecting its function. The aim of the present study was to evaluate the association between TP53 IVS3 16 bp genetic variant and the risk of breast cancer (BC) in women from western Mexico. Methods: The study included 220 women diagnosed with BC and 198 cancer-free controls. Clinical and demographic data were collected through structured questionnaires and verified with medical records. Genotyping of the TP53 IVS3 16 bp genetic variant was performed using polymerase chain reaction (PCR) and visualized on 6% polyacrylamide gels. Results: Compared to controls, women with BC more frequently reported a family history of the disease and menopausal status (p < 0.05). Genotypic analysis revealed that carriers of the D/I genotype and the combined D/I + I/I genotypes were associated with a reduced risk of BC in codominant (OR = 0.53; 95% CI 0.32–0.88) and dominant (OR = 0.57; 95% CI 0.35–0.93) models. Conclusions: The D/I and D/I + I/I genotypes in codominant and dominant models showed a lower risk against BC. More studies are needed to confirm these findings.


  • Open Access

    Implications of CD36 Gene Variants in Oxidative Stress Markers Between Mexican Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction

    by Brenda Parra-Reyna, Iliannis Yisel Roa-Bruzón, Texali Candelaria García-Garduño, Luis Felix Duany-Almira, Antonio Quintero-Ramos, Jorge Ramón Padilla-Gutiérrez, Héctor Enrique Flores-Salinas, Emmanuel Valdes-Alvarado, José Francisco Muñoz-Valle, Yeminia Valle

    Type 2 diabetes mellitus (T2DM) affects 90% of diabetes cases and worsens cardiovascular health by causing oxidative stress, which leads to oxidized LDL (oxLDL) and foam cell formation, contributing to atherosclerosis. This study examined the relationship between CD36 gene variants, soluble CD36 (sCD36), oxLDL, and MDA-LDL in T2DM and ST-segment elevation myocardial infarction (STE-T2DM) patients in western Mexico. The analysis included 400 T2DM patients, 400 STE-T2DM patients, and 400 healthy controls. Results showed that STE-T2DM patients were older, mainly male, and had higher rates of smoking, sedentarism, and hypertension. Both diabetic groups exhibited elevated triacylglycerols and low HDL, with significantly higher C-reactive protein in STE-T2DM (p < 0.0001). No significant differences in CD36 gene variant frequencies were found, but sCD36 levels were elevated in STE-T2DM, with associations to specific genotypes. oxLDL was higher in STE-T2DM compared to controls (p = 0.0268). Binary logistic regression analysis identified male sex, younger age, sedentarism, and rs3173798 T/T genotype as independent risk factors for myocardial infarction (AUC: 0.9267, p < 0.0001). Elevated sCD36 levels may reflect atherosclerosis progression in diabetes, indicating the need for further studies to clarify CD36’s role in cardiometabolic dysfunction. These findings highlight CD36’s involvement in oxidative stress responses through its interaction with oxLDL and MDA-LDL, suggesting its potential role as a molecular target in antioxidant defense mechanisms.


  • Open Access

    Table 3 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women

    by Daniela Alves da Quinta, Darío Rocha, Cristian Yáñez, Renata Binato, Sheila Coelho Soares-Lima, Xiaosong Huang, Daiana Ganiewich, Valentina A. Zavala, Monica Sans, Alejandra Lopez-Vazquez, et al.

    Univariate and multivariate Cox proportional hazard models for overall survival for every 10% increase of EUR or IA ancestry

  • Open Access

    Figure 1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women

    by Daniela Alves da Quinta, Darío Rocha, Cristian Yáñez, Renata Binato, Sheila Coelho Soares-Lima, Xiaosong Huang, Daiana Ganiewich, Valentina A. Zavala, Monica Sans, Alejandra Lopez-Vazquez, et al.

    Population structure of the 951 patients with breast cancer of the LACRN-MPBCS cohort included in this study. A, ADMIXTURE ancestry estimations obtained assuming four ancestral components for each country of origin (B) Principal component analysis (PCA) of data from all LACRN-MPBCS patients (triangles) and 158 reference subjects (dots). The two principal components of variation are shown as PC1 and PC2. C and D, Boxplots showing the distribution of each ancestry component for the whole cohort and by country, respectively. Median ancestry and IQRs are depicted; whiskers extend up to 1.5 IQR. Values outside the inter-quartile range are shown as solid dots. AFR, African; EAS, East Asian; EUR, European; IA, Indigenous American.

  • Open Access

    Supplementary Information from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women

    by Daniela Alves da Quinta, Darío Rocha, Cristian Yáñez, Renata Binato, Sheila Coelho Soares-Lima, Xiaosong Huang, Daiana Ganiewich, Valentina A. Zavala, Monica Sans, Alejandra Lopez-Vazquez, et al.

    Supplementary information and List of LACRN Investigators